title: New way to individualize pulmonary embolism initial anticoagulant treatment-using adequate approved doses of rivaroxaban.
authors.affiliation: Department of Cardiology, Clinical Center and Medical Faculty, University of Nis, Nis, Serbia. Electronic address: gkoracevic@yahoo.com.
authors.forename: Goran P
authors.initials: GP
authors.lastname: Koracevic
mesh_terms: D004305:Dose-Response Relationship, Drug; D065427:Factor Xa Inhibitors / Q000008:administration & dosage*; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000188:drug therapy*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*
chemical_list: D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban